Nectar Lifesci. (NECLIFE)
TURNAROUNDScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹12.09 |
| Market Cap | ₹237 Cr |
| P/E Ratio | 0 |
| ROCE | -5.36% |
| ROE | -32.94% |
| Dividend Yield | 0% |
| Profit Growth | -9,026.09% |
| Debt/Equity | 0.64 |
| Sales Growth | -100% |
| Promoter Holding | 51.84% |
| 52-Week Range | ₹9.3 — ₹24.89 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹56.14 |
Nectar Lifesci. trades with ROCE of -5.36%, ROE of -32.94%, profit growth of -9,026.09%, debt-to-equity of 0.64.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer